International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers
暂无分享,去创建一个
Jan Lubinski | Fergus Couch | Ping Sun | Barry Rosen | Peter Ainsworth | F. Couch | J. Klijn | P. Møller | W. Foulkes | S. Manoukian | J. Lubiński | E. Friedman | N. Tung | B. Rosen | S. Domchek | S. Narod | H. Lynch | P. Ainsworth | K. Metcalfe | P. Sun | P. Ghadirian | C. Kim-sing | J. Gronwald | T. Wagner | Siranoush Manoukian | Henry Lynch | Susan Domchek | Jacek Gronwald | Pal Moller | Steven A. Narod | Eitan Friedman | Nadine Tung | Parviz Ghadirian | Kelly A. Metcalfe | Daphna Birenbaum‐Carmeli | William D. Foulkes | Jan Klijn | Charmaine Kim‐Sing | Teresa Wagner | D. Birenbaum-Carmeli | E. Friedman
[1] J Chang-Claude,et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. , 1998, American journal of human genetics.
[2] J. Hopper,et al. Risk‐reducing surgery, screening and chemoprevention practices of BRCA1 and BRCA2 mutation carriers: a prospective cohort study , 2006, Clinical genetics.
[3] Ellen Warner,et al. Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] S. Narod,et al. Psychosocial functioning in women who have undergone bilateral prophylactic mastectomy , 2004, Psycho-oncology.
[5] J. Moatti,et al. Physicians' attitudes towards mammography and prophylactic surgery for hereditary breast/ovarian cancer risk and subsequently published guidelines , 2000, European Journal of Human Genetics.
[6] P. Tonin,et al. A descriptive study of BRCA1 testing and reactions to disclosure of test results , 1997, Cancer.
[7] J. Hopper,et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. , 2003, American journal of human genetics.
[8] D J Schaid,et al. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. , 1999, The New England journal of medicine.
[9] T. Sellers,et al. Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. , 2001, Journal of the National Cancer Institute.
[10] C. Isaacs,et al. Tamoxifen as chemoprevention in BRCA1 and BRCA2 mutation carriers with breast cancer: a pilot survey of physicians. , 2003, Journal of Clinical Oncology.
[11] C. Isaacs,et al. Bilateral prophylactic oophorectomy and ovarian cancer screening following BRCA1/BRCA2 mutation testing. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] H. D. de Koning,et al. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. , 2004, The New England journal of medicine.
[13] S. Narod,et al. Breast cancer risk perception among women who have undergone prophylactic bilateral mastectomy. , 2002, Journal of the National Cancer Institute.
[14] C K Redmond,et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. , 1999, Journal of the National Cancer Institute.
[15] P. Oefner,et al. Attitude towards prophylactic surgery and effects of genetic counselling in families with BRCAmutations , 2000, British Journal of Cancer.
[16] D. Horsman,et al. Variation in Rates of Uptake of Preventive Options in BRCA1 and BRCA2 Mutation Carriers Across Canada , 2007 .
[17] P. Oefner,et al. Attitude towards prophylactic surgery and effects of genetic counselling in families with BRCA mutations. Austrian Hereditary Breast and Ovarian Cancer Group. , 2000, British journal of cancer.
[18] Ellen Warner,et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination , 2004, JAMA.
[19] J. Klijn,et al. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. , 2001, The New England journal of medicine.
[20] M. Stefanek,et al. The practice of prophylactic mastectomy: a survey of Maryland surgeons. , 1995, American journal of public health.
[21] Joan Leach,et al. Expert heads a'rolling Melissa Leach Ian , 2005, The Lancet.
[22] F. Couch,et al. Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation. , 2006, JAMA.
[23] W. Foulkes,et al. An evaluation of needs of female BRCA1and BRCA2 carriers undergoing genetic counselling , 2000, Journal of medical genetics.
[24] R. Croyle,et al. Genetic testing for a BRCA1 mutation: Prophylactic surgery and screening behavior in women 2 years post testing , 2003, American journal of medical genetics. Part A.
[25] K. Heimdal,et al. Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study , 2000, The Lancet.
[26] T. Rebbeck,et al. Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] S. Narod,et al. The use of preventive measures among healthy women who carry a BRCA1 or BRCA2 mutation , 2005, Familial Cancer.
[28] M. Yaffe,et al. American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography , 2007, CA: a cancer journal for clinicians.
[29] A R Padhani,et al. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS) , 2005, The Lancet.
[30] S. Fosså,et al. Incidence of metachronous testicular cancer in patients with extragonadal germ cell tumors. , 2001, Journal of the National Cancer Institute.
[31] J. Klijn,et al. One Year Follow-Up of Women Opting for Presymptomatic Testing for BRCA1 and BRCA2: Emotional Impact of the Test Outcome and Decisions on Risk Management (Surveillance or Prophylactic Surgery) , 2002, Breast Cancer Research and Treatment.
[32] R. Croyle,et al. Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing. , 2000, Preventive medicine.
[33] P. Devilee,et al. Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation , 2000, The Lancet.